Kepemilikan Institusional dan Dana - Pembeli
Pemegang saham utama yang telah membuka posisi baru di Mereo BioPharma Group plc - Depositary Receipt (Common Stock) meliputi FBTAX - Fidelity Advisor Biotechnology Fund Class A, Paloma Partners Management Co, Millennium Management Llc, Dauntless Investment Group, LLC, LMR Partners LLP, Nomura Holdings Inc, DLD Asset Management, LP, Exome Asset Management LLC, Marex Group plc, Raymond James Financial Inc, Skopos Labs, Inc., dan EverSource Wealth Advisors, LLC .
Halaman ini menunjukkan perubahan dalam struktur kepemilikan dengan mencantumkan lembaga, dana, dan pemegang saham utama yang telah meningkatkan kepemilikan mereka atau membuka posisi baru pada periode pelaporan terakhir. Baris berwarna hijau menunjukkan posisi baru. Klik tautan ikon untuk melihat riwayat transaksi selengkapnya.
Tingkatkan ke versi premium untuk membuka data premium.
Tanggal File | Sumber | Investor | Ketik | Presyo ng Avg (Silangan) |
Saham | Δ Saham (%) |
Dilaporkan Nilai ($1000) |
Nilai Δ (%) |
Alokasi Port (%) |
|
---|---|---|---|---|---|---|---|---|---|---|
2025-08-13 | 13F | Renaissance Technologies Llc | 1,480,471 | 9.63 | 4,012 | 32.06 | ||||
2025-08-14 | 13F/A | Skopos Labs, Inc. | 849 | 2 | ||||||
2025-08-14 | 13F | Cubist Systematic Strategies, LLC | 21,099 | 57 | ||||||
2025-08-07 | 13F | Allworth Financial LP | 1,637 | 9.13 | 4 | 33.33 | ||||
2025-08-11 | 13F | Principal Securities, Inc. | 75 | 134.38 | 0 | |||||
2025-08-11 | 13F | Persistent Asset Partners Ltd | Call | 3,035 | 155.90 | 244 | 65.31 | |||
2025-07-14 | 13F | Avanza Fonder AB | 38,235 | 35.97 | 104 | 56.06 | ||||
2025-08-28 | NP | Tekla World Healthcare Fund | 1,681,804 | 29.33 | 4,558 | 55.79 | ||||
2025-07-31 | 13F | Caitong International Asset Management Co., Ltd | 4,544 | 206.20 | 12 | 300.00 | ||||
2025-08-12 | 13F | XTX Topco Ltd | 69,341 | 188 | ||||||
2025-08-14 | 13F | LMR Partners LLP | Call | 125,000 | 339 | |||||
2025-08-14 | 13F | Millennium Management Llc | Call | 153,000 | 415 | |||||
2025-08-19 | 13F | Newbridge Financial Services Group, Inc. | 13,000 | 18.18 | 35 | 45.83 | ||||
2025-08-19 | 13F | Marex Group plc | 10,000 | 27 | ||||||
2025-08-14 | 13F | Diadema Partners Lp | Call | 1,317,600 | 155.75 | 3,571 | 208.02 | |||
2025-08-14 | 13F | Two Sigma Advisers, Lp | 144,600 | 393.52 | 392 | 501.54 | ||||
2025-08-14 | 13F | Citadel Advisors Llc | 760,659 | 121.35 | 2,061 | 166.62 | ||||
2025-08-14 | 13F | Citadel Advisors Llc | Put | 99,800 | 187.61 | 270 | 246.15 | |||
2025-08-14 | 13F | Caption Management, LLC | 197,599 | 88.58 | 535 | 127.66 | ||||
2025-08-14 | 13F | Caption Management, LLC | Call | 437,500 | 43.44 | 1,186 | 72.74 | |||
2025-07-14 | 13F | GAMMA Investing LLC | 9,257 | 10.47 | 25 | 38.89 | ||||
2025-08-14 | 13F | Millennium Management Llc | 595,673 | 51.02 | 1,614 | 81.96 | ||||
2025-08-14 | 13F | Point72 Asset Management, L.P. | 59,200 | 65.29 | 160 | 100.00 | ||||
2025-08-14 | 13F | Jane Street Group, Llc | Call | 27,000 | 126.89 | 73 | 180.77 | |||
2025-08-14 | 13F | Jane Street Group, Llc | 247,441 | 70.88 | 671 | 106.15 | ||||
2025-08-14 | 13F | Frazier Life Sciences Management, L.P. | 9,440,112 | 20.72 | 25,583 | 45.40 | ||||
2025-08-14 | 13F | Susquehanna International Group, Llp | 361,542 | 107.33 | 980 | 149.74 | ||||
2025-08-14 | 13F | Susquehanna International Group, Llp | Call | 133,600 | 43.66 | 362 | 73.21 | |||
2025-08-14 | 13F | Susquehanna International Group, Llp | Put | 111,600 | 27.11 | 302 | 53.30 | |||
2025-08-14 | 13F | Dauntless Investment Group, LLC | 134,122 | 363 | ||||||
2025-08-28 | NP | Tekla Life Sciences Investors | 1,347,068 | 65.88 | 3,651 | 99.78 | ||||
2025-08-14 | 13F | Raymond James Financial Inc | 1,570 | 4 | ||||||
2025-08-12 | 13F | Proequities, Inc. | Put | 0 | 0 | |||||
2025-08-12 | 13F | Proequities, Inc. | Call | 0 | 0 | |||||
2025-08-12 | 13F | Proequities, Inc. | 0 | 0 | ||||||
2025-08-14 | 13F | Fmr Llc | 1,478,500 | 94.77 | 4,007 | 134.68 | ||||
2025-08-14 | 13F | Jane Street Group, Llc | Put | 221,700 | 2.02 | 601 | 22.95 | |||
2025-06-26 | NP | FBTAX - Fidelity Advisor Biotechnology Fund Class A This fund is a listed as child fund of Fmr Llc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 759,100 | 1,966 | ||||||
2025-08-13 | 13F | Quadrature Capital Ltd | 25,399 | 11.95 | 69 | 35.29 | ||||
2025-08-14 | 13F | Clearline Capital LP | 3,618,163 | 12.44 | 9,805 | 35.43 | ||||
2025-07-16 | 13F | Signaturefd, Llc | 187 | 1 | ||||||
2025-08-08 | 13F | Geode Capital Management, Llc | 92,534 | 0.41 | 251 | 20.77 | ||||
2025-08-12 | 13F | Rhumbline Advisers | 9,878 | 49.94 | 27 | 85.71 | ||||
2025-08-27 | 13F/A | Squarepoint Ops LLC | 20,668 | 15.26 | 56 | 40.00 | ||||
2025-08-14 | 13F | Two Sigma Investments, Lp | 659,158 | 168.82 | 1,786 | 224.14 | ||||
2025-08-14 | 13F | Aquatic Capital Management LLC | 26,930 | 73 | ||||||
2025-08-15 | 13F/A | Exome Asset Management LLC | 14,600 | 40 | ||||||
2025-08-05 | 13F | Simplex Trading, Llc | Put | 25,000 | 7.76 | 0 | ||||
2025-08-05 | 13F | Simplex Trading, Llc | 201,141 | 4,785.62 | 1 | |||||
2025-08-05 | 13F | Simplex Trading, Llc | Call | 199,200 | 250.09 | 1 | ||||
2025-07-14 | 13F | HealthInvest Partners AB | 764,901 | 96.13 | 2,073 | 136.26 | ||||
2025-08-12 | 13F | BlackRock, Inc. | 455,365 | 65.97 | 1,234 | 100.00 | ||||
2025-07-24 | 13F | Standard Life Aberdeen plc | 3,028,872 | 38.41 | 8,208 | 66.73 | ||||
2025-08-14 | 13F | Group One Trading, L.p. | Call | 489,900 | 13.25 | 1,328 | 36.38 | |||
2025-08-18 | 13F/A | Nomura Holdings Inc | 125,000 | 339 | ||||||
2025-07-15 | 13F | Significant Wealth Partners LLC | 22,261 | 61.65 | 60 | 100.00 | ||||
2025-08-14 | 13F | Goldman Sachs Group Inc | 3,090,068 | 45.35 | 8,374 | 75.08 | ||||
2025-08-14 | 13F | Group One Trading, L.p. | 139,559 | 307.10 | 378 | 390.91 | ||||
2025-08-14 | 13F | Paloma Partners Management Co | 296,659 | 804 | ||||||
2025-08-11 | 13F | Persistent Asset Partners Ltd | Put | 2,303 | 2,430.77 | 1,025 | 14,542.86 | |||
2025-08-13 | 13F/A | DLD Asset Management, LP | Call | 25,000 | 68 | |||||
2025-06-25 | NP | BBC - Virtus LifeSci Biotech Clinical Trials ETF | 44,024 | 170.19 | 114 | 132.65 | ||||
2025-08-13 | 13F | EverSource Wealth Advisors, LLC | 470 | 1 | ||||||
2025-08-14 | 13F | Artia Global Partners LP | 475,361 | 12.82 | 1,288 | 35.86 |